A ransomware attack at Motility Software Solutions, a provider of dealer management software (DMS), has exposed the sensitive data of 766,000 customers. Motility (formerly known as Systems 2000/Sys2K) ...

Anxiety affects gut motility, causing diarrhea or constipation, and can exacerbate conditions like IBS by altering intestinal contractions. Stress increases intestinal inflammation by weakening the ...

For most people, swallowing is second nature, but how does it occur, and why do some people have difficulty with it? Researchers at Kyushu University in Japan have started to tackle these questions by ...

In healthy swallowing, liquid quickly passes from the mouth to the stomach. In individuals with esophageal motility disorders, this process is disrupted. Fukuoka, Japan—For most people, swallowing is ...

When doctors first announced (in 1943) that penicillin would remove all signs of early syphilis in eight days, many a layman concluded that penicillin was a sure syphilis cure. But syphilologists, ...

PLANO, Texas, May 27, 2025 /PRNewswire/ -- AnX Robotica, a leader in advanced gastrointestinal diagnostic solutions, is proud to announce the FDA 510(k) clearance of MotiliCap™ and its companion ...

Men who’ve had COVID-19 may face hidden fertility risks. This study uncovers how the virus disrupts sperm health, even months after recovery. Study: COVID-19 infection was associated with poor sperm ...

Moderate exercise benefits GI health by improving motility, reducing constipation, and supporting gut health through neuroendocrine changes and increased vagal tone. High-intensity exercise can cause ...

Constipation is a digestive symptom that makes passing your stool difficult or painful. It involves straining during bowel movements, having hard or dry stools, and feeling like you haven't completely ...

Researchers have identified a new way to fight infections like Lyme disease and syphilis by disrupting the bacteria’s ‘motor,’ preventing it from spreading through the body. The findings could have ...

Gvoke VialDx is expected to be available in the third quarter of 2025. The Food and Drug Administration (FDA) has approved Gvoke VialDx ™ (glucagon) for intravenous use as a diagnostic aid during ...